CMKLR2 and neoplasm: This discrepancy raises the hypothesis that chemerin may act as a tumour suppressor through its binding to chemokine-like receptor 1 (CMKLR1) and G protein-coupled receptor 1 (GPR1) while potentially facilitating tumour progression by activating vascular endothelial growth [106].